Effect of doxorubicin plus cyclophosphamide on left ventricular ejection fraction in patients with breast cancer in the North Central Cancer Treatment Group N9831 Intergroup Adjuvant Trial. - Perez,E.A.; Suman,V.J.; Davidson,N.E.; Kaufman,P.A.; Martino,S..; Dakhil,S.R.; et,al.. (J Clin Oncol, 2004)